Development
Sanofi
SNY
$48.22
-$1.19-2.41%
NASDAQ
| 12/31/2023 | 06/30/2023 | 12/31/2022 | 09/30/2022 | ||
|---|---|---|---|---|---|
| Revenue | 7.27% | 0.67% | -4.11% | 2.27% | |
| Total Other Revenue | 25.55% | 1.71% | 55.15% | 41.24% | |
| Total Revenue | 8.44% | 0.73% | -1.71% | 3.70% | |
| Cost of Revenue | 13.75% | 2.70% | -3.98% | 1.10% | |
| Gross Profit | 5.87% | -0.12% | -0.58% | 4.81% | |
| SG&A Expenses | 7.59% | 2.83% | -6.18% | -0.27% | |
| Depreciation & Amortization | 32.57% | 21.04% | -2.77% | 52.30% | |
| Other Operating Expenses | 87.21% | 7.88% | -15.94% | -219.49% | |
| Total Operating Expenses | 18.06% | 3.82% | -4.61% | -4.91% | |
| Operating Income | -48.30% | -14.18% | 19.69% | 24.22% | |
| Income Before Tax | -106.43% | 26.95% | 158.99% | -22.14% | |
| Income Tax Expenses | -64.22% | 69.91% | 204.55% | -15.23% | |
| Earnings from Continuing Operations | -118.56% | 21.21% | 148.32% | -23.93% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | 105.55% | 72.75% | -409.33% | 90.14% | |
| Net Income | -118.80% | 24.81% | 146.01% | -23.18% | |
| EBIT | -48.30% | -14.18% | 19.69% | 24.22% | |
| EBITDA | -28.31% | -8.26% | 12.99% | 16.00% | |
| EPS Basic | -118.80% | 24.84% | 146.17% | -23.12% | |
| Normalized Basic EPS | -79.94% | -16.47% | 18.44% | -- | |
| EPS Diluted | -118.80% | 24.39% | 146.17% | -23.12% | |
| Normalized Diluted EPS | -79.94% | -16.47% | 18.44% | -- | |
| Average Basic Shares Outstanding | -0.03% | -0.02% | -0.07% | -0.08% | |
| Average Diluted Shares Outstanding | -0.03% | -0.02% | -0.07% | -0.08% | |
| Dividend Per Share | 11.29% | -- | -4.47% | -- | |
| Payout Ratio | -- | -- | -- | -- | |